BOSTON and NASHVILLE, Tenn., July 16, 2019 /PRNewswire/ -- The 2nd annual The Voice of Healthcare Summit – the No. 1

NEW YORK, July 16, 2019 /PRNewswire/ -- A molecular "trick" that kept our ancient ancestors from starving may now be contributing to the obesity epidemic, a new study finds. In starvation times, researchers say, animals were more likely to survive if they could hoard and stretch out their stored energy. Even if an animal secured a rare feast, evolution smiled

NEW YORK, July 16, 2019 /PRNewswire/ -- 94% of people affected by glioblastoma see providing the "best treatment regardless of personal financial situation" and 55% see "the elimination of co-pays" as essential. These are the headline results from 400+ people surveyed by OurBrainBank.The

MARLBOROUGH, Mass., July 16, 2019 /PRNewswire/ -- BTL, the manufacturer behind the game-changing EMSCULPT technology, is continuing to raise the bar in aesthetics and non-invasive body shaping. Today, the brand announced its latest FDA clearance for EMSCULPT, which is now FDA cleared to strengthen, firm and tone the arms and calves with the newly unveiled Small Cont

DENVER, July 16, 2019 /PRNewswire/ -- USA Weightlifting and Ascent, the first-ever performance nutrition partner of USA Weightlifting, are kicking off a fundraisi

WASHINGTON, July 16, 2019 /PRNewswire/ -- The American Kratom Association (AKA), representing more than 15 million kratom consumers in the United States, strongly endorsed the review and critique by Jack E. Henningfield, Ph.D. of the deficient Eggleston, et al. report on "Kratom Use and Toxicities in

WASHINGTON, July 16, 2019 /PRNewswire/ -- Responsible Telemedicine is a 501(c)(4) registered non-profit that works to safeguard the health and well-being of pati

COVINA, Calif., July 16, 2019 /PRNewswire/ -- Roger Sharma, Emanate Health's Chief Financial Officer and Executive Vice President, has been named to the

GARNER, N.C., July 16, 2019 /PRNewswire/ -- Lane and Associates Family Dentistry and North Carolina Oral Surgery and Orthodontics (NCOSO) are teaming up this summer in the fight against all Women's Cancer! 

SEATTLE, July 16, 2019 /PRNewswire/ -- Athira Pharma, Inc., a clinical-stage company dedicated to developing first-in-class therapies for Alzheimer's and Parkinson's that are focused on regeneration, today announced preliminary data from the Phase 1 clinical trial of its lead therapeutic candidate, NDX-1017, at the Alzheimer's Association International Conference 20